Healthpeak Properties Raises 2024 Guidance
Healthpeak Properties (NYSE: DOC) has increased its full-year 2024 guidance following strong performance across its lab, outpatient medical, and CCRC portfolios.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
Diluted FFO as Adjusted per share increased from
–$1.79 to$1.81 –$1.80 $1.82 -
Diluted AFFO per share increased from
–$1.56 to$1.58 –$1.57 $1.59 -
Total Merger-Combined Same-Store Cash (Adjusted) NOI growth increased from
3.5% –4.5% to4.0% –5.0%
Healthpeak published an updated Investor Presentation to incorporate the above-mentioned guidance increases, which includes required reconciliations under the appendix entitled “Reconciliation of Certain Non-GAAP Financial Measures.”
The presentation is available on Healthpeak’s investor relations website at https://ir.healthpeak.com.
ABOUT HEALTHPEAK PROPERTIES
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates and develops high-quality real estate focused on healthcare discovery and delivery. For more information regarding Healthpeak, visit www.healthpeak.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118124106/en/
Andrew Johns, CFA
Senior Vice President – Investor Relations
720-428-5400
Source: Healthpeak Properties, Inc.